These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22430398)

  • 1. [What is best for patients with STEMI on the way to primary percutaneous coronary intervention?].
    Opolski G
    Kardiol Pol; 2012; 70(3):222. PubMed ID: 22430398
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of infarct related artery patency after early abciximab administration on one-year mortality in patients with ST-segment elevation myocardial infarction (data from the EUROTRANSFER Registry).
    Rakowski T; Siudak Z; Dziewierz A; Birkemeyer R; Janzon M; Mielecki W; Zmudka K; Dubiel JS; Dudek D
    Kardiol Pol; 2012; 70(3):215-21. PubMed ID: 22430397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summary of recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction.
    Montalescot G; Andersen HR; Antoniucci D; Betriu A; de Boer MJ; Grip L; Neumann FJ; Rothman MT
    Heart; 2004 Jun; 90(6):676-7. PubMed ID: 15145878
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion - results of the Austrian multi-centre randomized ReoPro-BRIDGING Study.
    Gyöngyösi M; Domanovits H; Benzer W; Haugk M; Heinisch B; Sodeck G; Hödl R; Gaul G; Bonner G; Wojta J; Laggner A; Glogar D; Huber K;
    Eur Heart J; 2004 Dec; 25(23):2125-33. PubMed ID: 15571828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facilitation of primary PCI with ReoPro.
    van 't Hof AW; Rasoul S; Ottervanger JP; Dambrink JH
    Eur Heart J; 2005 Aug; 26(15):1563-4; author reply 1564-5. PubMed ID: 15941724
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter by Niccoli et al regarding article, "intracoronary versus intravenous administration of abciximab in patients with st-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of st-segment elevation myocardial infarction (CICERO) trial".
    Niccoli G; Cosentino N; Crea F
    Circulation; 2011 Aug; 124(8):e230; author reply e231. PubMed ID: 21859979
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological facilitation of coronary intervention in ST-segment elevation myocardial infarction: time is of the essence.
    Gersh BJ; Stone GW
    JACC Cardiovasc Interv; 2010 Dec; 3(12):1292-4. PubMed ID: 21232724
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of angioplasty with stenting in acute myocardial infarction.
    Herrmann HC
    N Engl J Med; 2002 Aug; 347(5):367-8; author reply 367-8. PubMed ID: 12151478
    [No Abstract]   [Full Text] [Related]  

  • 9. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
    Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
    Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial.
    Fernández-Avilés F; Alonso JJ; Peña G; Blanco J; Alonso-Briales J; López-Mesa J; Fernández-Vázquez F; Moreu J; Hernández RA; Castro-Beiras A; Gabriel R; Gibson CM; Sánchez PL;
    Eur Heart J; 2007 Apr; 28(8):949-60. PubMed ID: 17244641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study.
    Armstrong PW;
    Eur Heart J; 2006 Jul; 27(13):1530-8. PubMed ID: 16757491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trials.
    Brodie BR; Gersh BJ; Stuckey T; Witzenbichler B; Guagliumi G; Peruga JZ; Dudek D; Grines CL; Cox D; Parise H; Prasad A; Lansky AJ; Mehran R; Stone GW
    J Am Coll Cardiol; 2010 Jul; 56(5):407-13. PubMed ID: 20650362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanical reperfusion therapy for acute myocardial infarction: Stent PAMI, ADMIRAL, CADILLAC and beyond.
    Brodie BR; Stuckey TD
    Heart; 2002 Mar; 87(3):191-2. PubMed ID: 11847146
    [No Abstract]   [Full Text] [Related]  

  • 14. Coronary stenting and abciximab in primary angioplasty for ST-segment-elevation myocardial infarction.
    De Luca G; Suryapranata H; Grimaldi R; Chiariello M
    QJM; 2005 Sep; 98(9):633-41. PubMed ID: 16040669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet reactivity and percutaneous coronary intervention: another clue in the quest for the Holy Grail of tailored antithrombotic therapy?
    Di Sciascio G; Mangiacapra F
    J Am Coll Cardiol; 2012 Jul; 60(5):378-80. PubMed ID: 22682552
    [No Abstract]   [Full Text] [Related]  

  • 16. On the use of abciximab in percutaneous coronary intervention.
    Iversen AZ
    Dan Med Bull; 2011 Aug; 58(8):B4312. PubMed ID: 21827726
    [No Abstract]   [Full Text] [Related]  

  • 17. Prehospital versus periprocedural abciximab in ST-elevation myocardial infarction treated by percutaneous coronary intervention.
    Pels K; Schröder J; Witzenbichler B; Müller D; Morguet A; Pauschinger M; Schultheiss HP; Arntz HR
    Eur J Emerg Med; 2008 Dec; 15(6):324-9. PubMed ID: 19078834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of infarct-related coronary artery patency and microcirculatory function after facilitated percutaneous primary coronary angioplasty: the FINESSE-ANGIO (Facilitated Intervention With Enhanced Reperfusion Speed to Stop Events-Angiographic) study.
    Prati F; Petronio S; Van Boven AJ; Tendera M; De Luca L; de Belder MA; Galassi AR; Imola F; Montalescot G; Peruga JZ; Barnathan ES; Ellis S; Savonitto S;
    JACC Cardiovasc Interv; 2010 Dec; 3(12):1284-91. PubMed ID: 21232723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early administration of small-molecule glycoprotein IIb/IIIa inhibitors before primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from randomized clinical trials.
    Dong L; Zhang F; Shu X
    J Cardiovasc Pharmacol Ther; 2010 Jun; 15(2):135-44. PubMed ID: 20435991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial).
    Cox DA; Stone GW; Grines CL; Stuckey T; Zimetbaum PJ; Tcheng JE; Turco M; Garcia E; Guagliumi G; Iwaoka RS; Mehran R; O'Neill WW; Lansky AJ; Griffin JJ;
    Am J Cardiol; 2006 Aug; 98(3):331-7. PubMed ID: 16860018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.